Coronavirus Vaccine Goes Into Phase 1 Trial

The first patients in Seattle, WA have been injected with a novel vaccine aimed at curbing COVID-19 infections in humans. The vaccine was introduced to a cohort of patients yesterday in hopes that it will trigger immunity to the rapidly developing virus.

Volunteers between 18 and 55 years old at the Kaiser Permanente Washington Health Research Institute were given the first of two doses…